ChemicalBook > CAS DataBase List > BAY-1163877

BAY-1163877

Product Name
BAY-1163877
CAS No.
1443530-05-9
Chemical Name
BAY-1163877
Synonyms
Rogaratinib;BAY-1163877;Rogaratinib (BAY1163877);Rogaratinib,inhibit,BAY 1163877,Fibroblast growth factor receptor,BAY-1163877,FGFR,Inhibitor;2-Piperazinone, 4-[[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methylbenzo[b]thien-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-;4-{[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f]-[1,2,4]triazin-7-yl]methyl}piperazin-2-one
CBNumber
CB43339855
Molecular Formula
C23H26N6O3S
Formula Weight
466.56
MOL File
1443530-05-9.mol
More
Less

BAY-1163877 Property

Density 
1.48±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:5.0(Max Conc. mg/mL);10.72(Max Conc. mM)
form 
Solid
pka
15.49±0.20(Predicted)
color 
White to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-8129
Product name
Rogaratinib
Purity
99.86%
Packaging
1mg
Price
$180
Updated
2021/12/16
ChemScene
Product number
CS-8129
Product name
Rogaratinib
Purity
99.86%
Packaging
5mg
Price
$540
Updated
2021/12/16
ChemScene
Product number
CS-8129
Product name
Rogaratinib
Purity
99.86%
Packaging
10mg
Price
$780
Updated
2021/12/16
ChemScene
Product number
CS-8129
Product name
Rogaratinib
Purity
99.86%
Packaging
50mg
Price
$2340
Updated
2021/12/16
ChemScene
Product number
CS-8129
Product name
Rogaratinib
Purity
99.86%
Packaging
100mg
Price
$3540
Updated
2021/12/16
More
Less

BAY-1163877 Chemical Properties,Usage,Production

Uses

Rogaratinib (BAY1163877) is a potent and selective fibroblast growth factor receptor (FGFR) inhibitor. Rogaratinib inhibits FGFRs with IC50s of 11.2 nM (FGFR1), <1 nM (FGFR2), 18.5 nM (FGFR3), 127 nM (VEGFR3/FLT4), 201 nM (FGFR4), respectively[1][2].

IC 50

FGFR1; FGFR2; FGFR3; FGFR4

References

[1] Heroult M, et al. Preclinical profile of BAY 1163877-a selective pan-FGFR inhibitor in phase 1 clinical trial[J]. Cancer Res, 2014, 74(suppl 19): 1739a.
[2] Kim SM, et al. Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy. Oncogenesis. 2016 Jul 18;5(7):e241. DOI:10.1038/oncsis.2016.48

BAY-1163877 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

BAY-1163877 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58

1443530-05-9, BAY-1163877Related Search:


  • BAY-1163877
  • Rogaratinib
  • 4-{[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f]-[1,2,4]triazin-7-yl]methyl}piperazin-2-one
  • Rogaratinib (BAY1163877)
  • 2-Piperazinone, 4-[[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methylbenzo[b]thien-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-
  • Rogaratinib,inhibit,BAY 1163877,Fibroblast growth factor receptor,BAY-1163877,FGFR,Inhibitor
  • 1443530-05-9